erythrosine has been researched along with Memory Disorders in 13 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperammonemia is a common finding in patients with methylmalonic acidemia." | 1.48 | Ammonia role in glial dysfunction in methylmalonic acidemia. ( Arend, J; Barbosa, S; do Nascimento, PS; Dos Santos, ARS; Fighera, MR; Furian, AF; Gabbi, P; Haupental, F; Nogueira, V; Oliveira, MS; Rodrigues, FS; Royes, LFF, 2018) |
| "Spatial learning and memory deficits were evaluated by radial arm maze (n=8 each group) up to 21 days post-TBI." | 1.38 | Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1α after traumatic brain injury (TBI). ( Ding, JY; Ding, Y; Fredrickson, V; Guthikonda, M; Kassem, H; Kreipke, CW; Peng, C; Rafols, JA; Schafer, S; Shenaq, M, 2012) |
| "Atorvastatin treatment was neuroprotective against cell degeneration induced by Aβ(1-40), reducing inflammatory and oxidative responses and increasing the expression of glutamatergic transporters." | 1.36 | Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. ( Bezerra, SC; de Bem, AF; Duarte, FS; Figueiredo, CP; Mancini, G; Piermartiri, TC; Prediger, RD; Rial, D; Tasca, CI, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naderali, E | 1 |
| Nikbakht, F | 1 |
| Ofogh, SN | 1 |
| Rasoolijazi, H | 1 |
| Gabbi, P | 1 |
| Nogueira, V | 1 |
| Haupental, F | 1 |
| Rodrigues, FS | 1 |
| do Nascimento, PS | 1 |
| Barbosa, S | 1 |
| Arend, J | 1 |
| Furian, AF | 1 |
| Oliveira, MS | 1 |
| Dos Santos, ARS | 1 |
| Royes, LFF | 1 |
| Fighera, MR | 1 |
| Majkutewicz, I | 1 |
| Kurowska, E | 1 |
| Podlacha, M | 1 |
| Myślińska, D | 1 |
| Grembecka, B | 1 |
| Ruciński, J | 1 |
| Plucińska, K | 1 |
| Jerzemowska, G | 1 |
| Wrona, D | 1 |
| Piermartiri, TC | 1 |
| Figueiredo, CP | 1 |
| Rial, D | 1 |
| Duarte, FS | 1 |
| Bezerra, SC | 1 |
| Mancini, G | 1 |
| de Bem, AF | 1 |
| Prediger, RD | 1 |
| Tasca, CI | 1 |
| Hua, F | 1 |
| Reiss, JI | 1 |
| Tang, H | 1 |
| Wang, J | 1 |
| Fowler, X | 1 |
| Sayeed, I | 1 |
| Stein, DG | 1 |
| Nemeth, CL | 1 |
| Shurte, MS | 1 |
| McTigue, DM | 1 |
| Nemeroff, CB | 1 |
| Neigh, GN | 1 |
| Santos, TO | 1 |
| Mazucanti, CH | 1 |
| Xavier, GF | 1 |
| Torrão, AS | 1 |
| Shenaq, M | 1 |
| Kassem, H | 1 |
| Peng, C | 1 |
| Schafer, S | 1 |
| Ding, JY | 1 |
| Fredrickson, V | 1 |
| Guthikonda, M | 1 |
| Kreipke, CW | 1 |
| Rafols, JA | 1 |
| Ding, Y | 1 |
| Ballok, DA | 1 |
| Woulfe, J | 1 |
| Sur, M | 1 |
| Cyr, M | 1 |
| Sakic, B | 1 |
| Belcher, AM | 1 |
| O'Dell, SJ | 1 |
| Marshall, JF | 1 |
| Gong, Y | 1 |
| Meyer, EM | 1 |
| Meyers, CA | 1 |
| Klein, RL | 1 |
| King, MA | 1 |
| Hughes, JA | 1 |
| Maiti, P | 1 |
| Singh, SB | 1 |
| Muthuraju, S | 1 |
| Veleri, S | 1 |
| Ilavazhagan, G | 1 |
| Simões, PF | 1 |
| Silva, AP | 1 |
| Pereira, FC | 1 |
| Marques, E | 1 |
| Grade, S | 1 |
| Milhazes, N | 1 |
| Borges, F | 1 |
| Ribeiro, CF | 1 |
| Macedo, TR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification[NCT02225834] | Phase 4 | 50 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 other studies available for erythrosine and Memory Disorders
| Article | Year |
|---|---|
The role of rosemary extract in degeneration of hippocampal neurons induced by kainic acid in the rat: A behavioral and histochemical approach.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Epilepsy, Temporal Lobe; Excitatory Amino Acid | 2018 |
Ammonia role in glial dysfunction in methylmalonic acidemia.
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Ammonium Chloride; Animals; Behavior, Animal; Brain; | 2018 |
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Cholinesterases; Cytokines; Dimethyl Fumarate; Di | 2016 |
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, New | 2010 |
Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury.
Topics: Animals; Astrocytes; Behavior, Animal; Body Weight; Brain Injuries; Cell Death; Dose-Response Relati | 2012 |
Microembolism infarcts lead to delayed changes in affective-like behaviors followed by spatial memory impairment.
Topics: Analysis of Variance; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; CD11b Antige | 2012 |
Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Blood Glucose; Choline O-Acetyltransferase; Fl | 2012 |
Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1α after traumatic brain injury (TBI).
Topics: 2-Methoxyestradiol; Animals; Aquaporin 4; Aquaporins; Brain Damage, Chronic; Brain Edema; Brain Inju | 2012 |
Hippocampal damage in mouse and human forms of systemic autoimmune disease.
Topics: Aging; Animals; Choroid Plexus; Cyclophosphamide; Disease Models, Animal; fas Receptor; Female; Fluo | 2004 |
Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cell Count; Cocaine; Dextroamphet | 2005 |
Memory-related deficits following selective hippocampal expression of Swedish mutation amyloid precursor protein in the rat.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; | 2006 |
Hypobaric hypoxia damages the hippocampal pyramidal neurons in the rat brain.
Topics: Altitude Sickness; Animals; Apoptosis; DNA Fragmentation; Fluoresceins; Hippocampus; Hypoxia, Brain; | 2007 |
Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.
Topics: Animals; Central Nervous System Stimulants; Fluoresceins; Gliosis; Glutamic Acid; Hippocampus; Male; | 2007 |